0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      TCR Clonality and Genomic Instability Signatures as Prognostic Biomarkers in High Grade Serous Ovarian Cancer.

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Immune infiltration is a prognostic factor in high-grade serous ovarian carcinoma (HGSC) but immunotherapy efficacy is disappointing. Genomic instability is now used to guide the therapeutic value of PARP inhibitors. We aimed to investigate exome-derived parameters to assess the tumor microenvironment according to genomic instability profile.

          Related collections

          Author and article information

          Journal
          Cancers (Basel)
          Cancers
          MDPI AG
          2072-6694
          2072-6694
          Aug 31 2021
          : 13
          : 17
          Affiliations
          [1 ] Platform of Transfer in Biological Oncology, Georges François Leclerc Cancer Center-UNICANCER, 1 rue du Professeur Marion, 21000 Dijon, France.
          [2 ] Unité Mixte de Recherche (UMR) INSERM 1231, 7 Boulevard Jeanne d'Arc, 21000 Dijon, France.
          [3 ] Institut de Chimie Moléculaire Université de Bourgogne (ICMUB) UMR CNRS 6302, 21000 Dijon, France.
          [4 ] Department of Biology and Pathology of Tumors, Georges François Leclerc Cancer Center-UNICANCER, 1 rue du Professeur Marion, 21000 Dijon, France.
          [5 ] Department of Medical Oncology, Georges François Leclerc Cancer Center-UNICANCER, 1 rue du Professeur Marion, 21000 Dijon, France.
          [6 ] Laboratoire RESHAPE University Claude Bernard Lyon I, Department of Medical Oncology, Léon-Bérard Center, 28 rue Laennec, 69008 Lyon, France.
          [7 ] Maison de l'université Esplanade Erasme, University of Burgundy-Franche Comté, 21000 Dijon, France.
          [8 ] Genomic and Immunotherapy Medical Institute, Dijon University Hospital, 14 rue Paul Gaffarel, 21000 Dijon, France.
          Article
          cancers13174394
          10.3390/cancers13174394
          8430641
          34503204
          f3ff24a4-6a00-4136-a52a-8d49e527fa4a
          History

          biomarkers,prognostic,HGSC,HRD,TCR clonality
          biomarkers, prognostic, HGSC, HRD, TCR clonality

          Comments

          Comment on this article